THTX: Theratechnologies Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Ikkita OIVga qarshi dori vositalariga bog'liqlik va to'lanmagan qarzlar tufayli yuzaga kelgan xatarlar Theratechnologies Inc. (THTX) likvidligiga salbiy ta'sir ko'rsatmoqda, bu holat tarixiy P/E o'sish tendentsiyasi bilan tasdiqlangan. Shu bilan birga, 0.00 ko'rsatkichi maqsadli daraja vazifasini o'taydi. Biologik preparatlar logistikasining optimallashtirilganligi barqaror marjalarni ta'minlaydi, onkologiyada maqsadli ximioterapiya uchun innovatsion peptid konjugatlari esa kam uchraydigan patologiyalarni davolashda sezilarli raqobatbardoshlik ustunligini yaratadi.
Theratechnologies Inc. (THTX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Theratechnologies Inc.|THTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi theratech.com|THTX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Theratechnologies Inc|THTX - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Theratechnologies|Oraliq qoplash koeffitsiyenti theratech.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
THTX - Sof foyda|Kutilayotgan sof foyda Theratechnologies Inc.|THTX - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Theratechnologies, Inc|THTX - PEG multiplikatori|EV/EBITDA multiplikatori Theratechnologies Inc|THTX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Theratechnologies|THTX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi theratech.com|THTX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Theratechnologies Inc.
Kompaniyaning umumiy tahlili:THTX - Theratechnologies, Inc.
Xavfsizlik zaxirasi yuqori bo'lgan aktivlarni tanlash uchun P/E bozor koeffitsientini foyda o'sish sur'atlari bilan solishtiruvchi metrika ishlatiladi, bunda birdan past qiymat fundamental past baholanganlikdan dalolat beradi. O'sish aksiyalarining past baholanganlik koeffitsientini tahlil qilish orqali investor Theratechnologies Inc. (THTX) kompaniyasining ESG transformatsiyasi va laboratoriya ekologik xavfsizligiga sarflayotgan xarajatlari uzoq muddatli foyda dinamikasi bilan qanchalik oqlanganligini baholashi mumkin.
Theratechnologies Inc. kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|Pharvaris Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ABCL: PEG multiplikatori|tourmalinebio.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PGEN (Precigen) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|PEG multiplikatori immunome.com IMNM|GOSS: Narx-foyda va o‘sish multiplikatori|KalVista Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SEPN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pieris Corp (PVLA)|SVRA (Savara Inc.) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori rigel.com (RIGL)|PEG multiplikatori ANAB|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda aclaristx.com|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|TLSA (Tiziana Life Sciences Ltd.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|O‘sish sur’atiga tuzatilgan narx-foyda Ventyx Biosciences, Inc VTYX|PEG multiplikatori AVTX|eledon.com (ELDN) - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori AGEN (Agenus Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Climb Bio Inc. (CLYM)|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aTyr Pharmaceuticals|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori STTK|EQ: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CNTB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|IFRX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|X4 Pharmaceuticals, Inc. - PEG multiplikatori|Adicet Bio (ACET) - Narx-foyda va o‘sish multiplikatori|CELU (celularity.com) - Narx-foyda va o‘sish multiplikatori|INMB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori BRNS|KZR (kezarlifesciences.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori SABS|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Enlivex Therapeutics Ltd. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati QTTB (Q32 Bio Inc)|GOVX: Narx-foyda va o‘sish multiplikatori|EDSA (edesabiotech.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati CARM (Carisma Therapeutics Inc.)|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND: PEG multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INDP|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati affimed.com|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
